# Modafinil in Opioid Induced Sedation

> **NCT00267332** · PHASE3 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 90 (—)

## Conditions studied

- Cancer
- Pain

## Interventions

- **DRUG:** Modafinil

## Key facts

- **NCT ID:** NCT00267332
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 90 (—)
- **Why stopped:** Low accrual
- **Last updated:** 2018-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267332, "Modafinil in Opioid Induced Sedation". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00267332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*